Literature DB >> 9915636

Consensus statement on the diagnosis of multiple system atrophy.

S Gilman1, P A Low, N Quinn, A Albanese, Y Ben-Shlomo, C J Fowler, H Kaufmann, T Klockgether, A E Lang, P L Lantos, I Litvan, C J Mathias, E Oliver, D Robertson, I Schatz, G K Wenning.   

Abstract

We report the results of a consensus conference on the diagnosis of multiple system atrophy (MSA). We describe the clinical features of the disease, which include four domains: autonomic failure/urinary dysfunction, parkinsonism and cerebellar ataxia, and corticospinal dysfunction. We set criteria to define the relative importance of these features. The diagnosis of possible MSA requires one criterion plus two features from separate other domains. The diagnosis of probable MSA requires the criterion for autonomic failure/urinary dysfunction plus poorly levodopa responsive parkinsonism or cerebellar ataxia. The diagnosis of definite MSA requires pathological confirmation.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  1998        PMID: 9915636

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  38 in total

1.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.

Authors:  D E Riley; T C Chelimsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Patients' choice of portable folding chairs to reduce symptoms of orthostatic hypotension.

Authors:  A A Smit; W Wieling; T L Opfer-Gehrking; H M van Emmerik-Levelt; P A Low
Journal:  Clin Auton Res       Date:  1999-12       Impact factor: 4.435

3.  Neurology training in the United Kingdom: a diagnostic analysis of over 5000 patients.

Authors:  Paul Maddison
Journal:  J Neurol       Date:  2005-03-04       Impact factor: 4.849

4.  When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study.

Authors:  T Yamamoto; R Sakakibara; T Uchiyama; Z Liu; T Ito; Y Awa; K Yamamoto; M Kinou; T Yamanishi; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

5.  Causes of death in multiple system atrophy.

Authors:  Spiridon Papapetropoulos; Alexander Tuchman; Daniel Laufer; Athanassios G Papatsoris; Nektarios Papapetropoulos; Deborah C Mash
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03       Impact factor: 10.154

6.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

7.  Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.

Authors:  Canan Ozsancak; Pascal Auzou; Kathy Dujardin; Niall Quinn; Alain Destée
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

8.  The cardiovascular effects of metoclopramide in multiple system atrophy and pure autonomic failure.

Authors:  F Magnifico; G Pierangeli; G Barletta; C Candela; G Bonavina; M Contin; P Cortelli
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

Review 9.  Optimizing clinical trial design for multiple system atrophy: lessons from the rifampicin study.

Authors:  Wolfgang Singer; Phillip A Low
Journal:  Clin Auton Res       Date:  2015-03-13       Impact factor: 4.435

10.  Loss of A5 noradrenergic neurons in multiple system atrophy.

Authors:  Eduardo E Benarroch; Ann M Schmeichel; Phillip A Low; Paola Sandroni; Joseph E Parisi
Journal:  Acta Neuropathol       Date:  2008-02-23       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.